Results 261 to 270 of about 213,305 (310)

Pharmaceutical Economics [PDF]

Business Economics, 2008
The role economists play in shaping the direction and outcome of business research and policy decisions of a very important part of the healthcare industry—the pharmaceutical industry.Business Economics (2008) 43, 65–68; doi:10.2145 ...
openaire  

Some of the next articles are maybe not open access.

Related searches:

Pharmaceutical Economics and Policy

2018
Pharmaceuticals play a critical role in the raging debate over how best to advance and improve healthcare in the United States and the rest of the world. Using the analytical tools of economics, this book explores the conflicting priorities and aims of the biopharmaceutical industry. It starts out by describing the supply side of pharmaceuticals in all
Stuart O. Schweitzer, Z. John Lu
openaire   +1 more source

Economics and Structure of the Generic Pharmaceutical Industry

Journal of the American Pharmaceutical Association (1996), 2001
To review key economic trends of the generic medication market and analyze the changing structure of the generic medication industry.Articles were indexed initially using terms such as generic medications, generic drugs, multisource medications, and multisource drugs.
D M, Kirking, F J, Ascione, C A, Gaither, L S, Welage   +3 more
openaire   +2 more sources

Pharmaceutical Economics And Policy

2006
Abstract The pharmaceutical industry is praised as a world leader in high technology innovation and the creator of products that increase both longevity and quality of life for people throughout the world. At the same time, the industry is also criticized for its marketing and pricing practices and for its apparent anticompetitive ...
openaire   +1 more source

Health Economics in the Canadian Pharmaceutical Industry

PharmacoEconomics, 1999
To assess the goals, strategic focus, structure, capabilities, activities and effectiveness of health economics (HE) departments in the Canadian pharmaceutical industry, to examine how these have evolved, and the implications of HE in the future of the pharmaceutical industry.A mixture of telephone and face-to-face interviews with members of the HE ...
L, Assiff, M R, Pollock, P, Manzi, B, Faienza, D, Menon   +4 more
openaire   +2 more sources

Economics of the Pharmaceutical Industry

Journal of Economic Literature, 2018
The pharmaceutical industry accounts for a substantial chunk of the US economy's research and development investments, which have resulted in significant medical breakthroughs. At the same time, the costs of pharmaceutical products continue to rise, as does pressure to adopt direct or indirect controls on pharmaceutical prices.
openaire   +1 more source

Economics, Pharmaceuticals, and Pharmacoeconomics

Medical Decision Making, 1998
M, Johannesson, B J, O'Brien
openaire   +2 more sources

Pharmaceutical economics

ECONOMIA E POLITICA INDUSTRIALE, 2014
Comanor, William S., Schweitzer, Stuart O.   +1 more
openaire   +1 more source

Issues in Mandatory Economic Assessment of Pharmaceuticals

Health Affairs, 1992
Australia is expanding assessment of pharmaceuticals by requiring economic evaluation before drugs are marketed. While such assessment is voluntary at first for pharmaceutical firms, it becomes mandatory by January 1993. Michael Drummond has provided an excellent analysis of this new policy initiative, describing in detail the means, methods, and ...
openaire   +2 more sources

Economic impact of poor compliance with pharmaceuticals

Expert Review of Pharmacoeconomics & Outcomes Research, 2002
Poor compliance with prescribed drug regimens is a widespread phenomenon which results in decreased efficacy and is often associated with increased medical expenditures due to treatment failure and/or adverse events. This review examines the issues relating to the measurement of compliance and the clinical and economic consequences of noncompliant drug
openaire   +2 more sources